Acute hypotension caused by inhibitors of angiotensin conversion enzyme. Description of an unusual case
Finzi, G.; Megha, A.; Poli, T.; Talignani, G.
Recenti Progressi in Medicina 78(4): 154-156
1987
ISSN/ISBN: 0034-1193 PMID: 2819999 Document Number: 301312
Document emailed within 1 workday
Related Documents
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759Grecu, M.; Olteanu, R.O.; Olteanu, S.S.; Georgescu, C.ăt.ăl.A. 2007: Effectiveness of angiotensin-converting enzyme inhibitors in the maintenance of sinus rythm after conversion of arterial fibrillation Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(3): 607-612
Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Preobrazhenskiĭ, D.V.; Sidorenko, B.A.; Pershukov, I.V.; Batyraliev, T.A.; Pataraia, S.A. 2006: Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril Kardiologiia 46(5): 89-95
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Elorriaga-Sánchez, F.; Corrales-Bobadilla, H.; Sosa-Trinidad, E.; Domínguez-Quezada, B. 2001: Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case Gaceta Medica de Mexico 137(3): 249-252
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Jasik, M.; Zdrojewicz, Z.; Stawicki, S. 1999: The activity of renin-angiotensin-aldosterone system (RAA) and possibilities of application angiotensin converting enzyme inhibitors (ACE I) in selected diseases of endocrine glands Wiadomosci Lekarskie 52(3-4): 202-210
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Inzhutova, A.I.; Salmina, A.B.; Petrova, M.M. 2007: Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes Kardiologiia 47(8): 49-52
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Kondo, K.; Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Morotomi, Y.; Tanaka, K. 1985: Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system Nihon Jinzo Gakkai Shi 27(3): 337-342
Tabata, S.; Yamazaki, H.; Ohtake, Y.; Hayashi, S. 1990: Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats Arzneimittel-Forschung 40(8): 865-867
Abe, K. 1985: Angiotensin converting enzyme inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 43(5): 949-955